Revlimid, also known as lenalidomide, is an immunomodulatory drug that is primarily used to treat certain types of cancer. It is a derivative of thalidomide and has shown significant efficacy in treating multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma (MCL).
